subject: Global Rnai Industry Witnessing Strong R&d Drugs In Pipeline [print this page] A new research report by RNCOS entitled, Global RNAi Market Analysis, says that the global RNAi market has seen overflowing innovations and promising developments during the last few years. Research activities are vigorous at the industrial and at the academic level as well. The global industry presents a very strong pipeline portfolio enhancing a promising growth of the industry. Majority of the RNAi pipeline products are in the Phase-1 of the clinical trial development. Advanced trials are increasing and RNAi therapeutics is particularly showing great promise.
RNAi-based research is being focused on high-throughput target discovery and target validation Fuelled by molecular targeting and increasing genome discoveries. Strategic activity in this field is also progressing as significant growth in this sector requires high skills. Through consolidated developments, the segmented industry players are intensifying competition and gaining market presence. According to the latest report by RNCOS, the global RNAi industry is set to grow at a CAGR of around 16% from 2011 to 2015.
The report, spread in over 100 pages provides a clear understanding of the RNAi market and its current status, globally. Recent industry activities in key geographies, such as US, Europe, and Asia-Pacific regions have been covered in this report. RNAi applications in broad areas, such as Therapeutics, Drug Discovery and Development and Agriculture have been discussed here. Products and services of key market players along with brief information about their businesses have also been covered in this report. The report also covers a detailed analysis on therapeutics in the pipeline, and expected to evolve enormously in the future. An analysis of the key market trends and key competitor analysis provides a holistic understanding to the reader on the industrys current state.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM329.htm
Some of our Related Reports are:
- Cancer Monoclonal Antibodies Market to 2015 (http://www.rncos.com/Report/IM375.htm)
- Global Biosimilars Market Forecast to 2015 (http://www.rncos.com/Report/IM379.htm)
- US Biotech Market Analysis (http://www.rncos.com/Report/IM0300.htm)
- Global miRNA Market Outlook (http://www.rncos.com/Report/IM286.htm)
- Global HIV Therapeutics Market Analysis (http://www.rncos.com/Report/IM361.htm)
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.
by: Shushmul Maheshwari
welcome to Insurances.net (https://www.insurances.net)
